Article Dans Une Revue Bioanalysis Année : 2015

Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration

Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration.

Résumé

Adalimumab is a therapeutic antibody used for treating inflammatory diseases. To understand interindividual PK variability, there is a need to develop and validate an assay to measure serum adalimumab concentrations.

Fichier non déposé

Dates et versions

hal-02372930 , version 1 (20-11-2019)

Identifiants

Citer

Celine Desvignes, Soujanya Edupuganti, François Darrouzain, Anne-Claire Duveau, Amy Loercher, et al.. Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration. Bioanalysis, 2015, 7 (10), pp.1253-1260. ⟨10.4155/bio.15.30⟩. ⟨hal-02372930⟩

Collections

84 Consultations
0 Téléchargements

Altmetric

Partager

  • More